lapatinib has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Gan, L; Li, L; Liu, B; Liu, L; Shan, Z; Xiao, C; Xu, T; Yao, S; Zhao, Y; Zhong, L | 1 |
1 other study(ies) available for lapatinib and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
[Mechanism underlying inhibition of proliferation and promotion of apoptosis by lapatinib in HL60 cells].
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; HL-60 Cells; Humans; Lapatinib; Leukemia, Promyelocytic, Acute; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction | 2017 |